The application also wants to include an investigator’s brochure, which outlines the details of how the study will function: not just simply how much in the drug might be utilised, but why and with what other approaches. In MAPS’s trials, scientists dose PTSD sufferers with copyright in advance of guiding them through a psychotherapy session—